Vaccinex Inc

NASDAQ:VCNX   12:13:48 AM EDT
0.49
+0.04 (+8.70%)
Earnings Announcements

Vaccinex reports Q2 results

Published: 08/15/2022 13:34 GMT
Vaccinex Inc (VCNX) - Vaccinex Reports Second Quarter 2022 Results and Provides Corporate Update; Excellent Progress in Pepinemab Clinical Programs.
Vaccinex Inc - Qtrly Loss per Share $0.13.
Vaccinex - Initiated Randomized, Double-blind, Phase 1/2a Signal-ad Study in 40 Subjects With Early Ad, Sees Study to Complete Enrollment by Q1 2023.